Font + | -

Erlangen, 8 June 2017 – Dr. Arthur Meßner, who has been a member of the Management Board of HumanOptics AG since 2001, asked the company’s Supervisory Board to prematurely release him from his appointment to the Management Board and from his related employment contract at the end of financial year 2016/2017, i.e. as per 30 June 2017, in order to pursue new professional challenges.

The Supervisory Board of HumanOptics AG has accepted Dr. Meßner’s decision with great regret. Its members would like to thank Dr. Meßner for many years of excellent teamwork, dedicated commitment and outstanding achievements, especially in recent years, in which HumanOptics AG has progressed to a new level in terms of company size. They wish him all the best for his future career.

Dr. Meßner’s current responsibilities will be taken over by CEO Dr. Pierre Billardon in the future. Dr. Meßner will continue to support HumanOptics as an advisor.

HumanOptics AG achieved significant sales growth over the past fiscal year. In view of the current corporate growth strategy, the supervisory board has decided to expand the executive board with the addition of Dr. Pierre Billardon, an experienced manager in the industry. The aim is further development of the innovative strength of the company. Effective January 10, 2017, as CEO Dr. Pierre Billardon assumes responsibility for the marketing, sales, and production departments.

Dr. Billardon has excellent management expertise and many years experience in ophthalmology. Apart from in positions in international management at Ciba Vision and Novartis in Switzerland, he spent many years at Carl Zeiss, from 2010 as president of Carl Zeiss France. Most recently, he held the position of president of Alcon France. Dr. Billardon holds a Ph.D. in pharmaceutical engineering.

Former CEO Dr. Arthur Meßner's role on the executive board will be increasingly devoted to the areas of research and development, as well as quality management and product approval.


HumanOptics has consistently expanded its comprehensive product range:

The MICROSIL® DIAPHRAGM DP 4128 is a pupillary closed diaphragm made of foldable silicone with an embedded polymer fabric for increased tear strength of the fixation sutures. The special implant offers posterior segment specialists an ideal option for the treatment of hypotonic, aphakic eyes for the permanent or temporary compartmentalization of the anterior and posterior segment of the eye.

- Overall diameter: 12.8 mm
- Central transparent zone: 3.5 mm
- Material: Hydrophobic silicone elastomer with embedded polymer meshwork

New toric multifocal IOL will expand our premium segment

The new ToricaDiff  conveniently offers patients with prevalent corneal astigmatism full range of comfortable vision at all distances. This premium IOL features a meridional aspheric optic in HD quality. Due to the reliable rotational stability of the monobloc design, the ToricaDiff shows excellent refractive outcomes, leading to a high degree of patient satisfaction.

- Sph: 10.0 to 30.0 D in 0.5 D steps
- Cyl: 1.0 to 6.0 D in 0.5 D steps
- Near addition +3.5 D
- HD optic
- Aberration-free
- 360° LEC barrier
- Optional blue light protection
- Also available preloaded in Safeloader® autoloading container